Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
A Contemporary Report of Low-Dose-Rate Brachytherapy for Prostate Cancer Using MRI for Risk Stratification: Disease Outcomes and Patient-Reported Quality of Life.
Journal: Cancers
Published: January 11, 2023
STK11 Inactivation Predicts Rapid Recurrence in Inoperable Early-Stage Non-Small-Cell Lung Cancer.
Journal: JCO precision oncology
Published: January 05, 2023
Brain arteriovenous malformation flow after stereotactic radiosurgery: Role of quantitative MRA.
Journal: Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences
Published: October 20, 2022
Highly aneuploid non-small cell lung cancer shows enhanced responsiveness to concurrent radiation and immune checkpoint blockade.
Journal: Nature cancer
Published: February 22, 2022
Beyond the Visible Spectrum: Considering the Oligometastatic Hypothesis in the Light of a New Era.
Journal: International journal of radiation oncology, biology, physics
Published: February 14, 2022
Hematuria following Post-Prostatectomy Radiotherapy: Incidence Increases with Long-Term Followup.
Journal: The Journal of urology
Published: January 20, 2022
Combined radio-immunotherapy: An opportunity to increase the therapeutic ratio of oligometastasis-directed radiotherapy.
Journal: Neoplasia (New York, N.Y.)
Published: November 18, 2021
Decreased overall survival in patients with locally advanced head and neck cancer receiving definitive radiotherapy and concurrent cetuximab: National Cancer Database analysis.
Journal: Head & neck
Published: October 10, 2021
Chemoradiation for Anal Cancer: Clinical Outcomes and Strategies to Optimize the Therapeutic Ratio According to HPV Status.
Journal: Seminars in radiation oncology
Published: August 30, 2021
Treatment of Cancer with Radio-Immunotherapy: What We Currently Know and What the Future May Hold.
Journal: International journal of molecular sciences
Published: July 20, 2021
CDKN2A loss-of-function predicts immunotherapy resistance in non-small cell lung cancer.
Journal: Scientific reports
Published: July 16, 2021
Last Updated: 09/26/2026